Page last updated: 2024-08-21

dihydroergotamine and prazosin

dihydroergotamine has been researched along with prazosin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Müller-Schweinitzer, E1
Kato, R; Nakadate, T; Nakaki, T1
Morris, JL1
Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM1
Johnson, ZB; Looper, ML; Rorie, RW; Rosenkrans, CF; Wang, H1
Buonvicino, D; Chiarugi, A; De Cesaris, F; Muzzi, M1

Reviews

1 review(s) available for dihydroergotamine and prazosin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for dihydroergotamine and prazosin

ArticleYear
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction

1984
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
    Naunyn-Schmiedeberg's archives of pharmacology, 1984, Volume: 327, Issue:4

    Topics: Cocaine; Dihydroergotamine; Humans; In Vitro Techniques; Norepinephrine; Pizotyline; Prazosin; Receptors, Adrenergic, alpha; Receptors, Serotonin; Saphenous Vein; Vasoconstriction; Yohimbine

1984
Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.
    Naunyn-Schmiedeberg's archives of pharmacology, 1980, Volume: 313, Issue:2

    Topics: Animals; Dihydroergotamine; Epinephrine; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Phenoxybenzamine; Phentolamine; Prazosin; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Yohimbine

1980
Blockade of noradrenaline-induced constrictions by yohimbine and prazosin differs between consecutive segments of cutaneous arteries in guinea-pig ears.
    British journal of pharmacology, 1994, Volume: 113, Issue:4

    Topics: Animals; Arteries; Dihydroergotamine; Ear, External; Female; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Regional Blood Flow; Serotonin; Vasoconstriction; Yohimbine

1994
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine

1999
Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.
    In vitro cellular & developmental biology. Animal, 2009, Volume: 45, Issue:8

    Topics: Animals; Cattle; Chelating Agents; Cholera Toxin; Cyclic AMP; Dihydroergotamine; Egtazic Acid; Ergot Alkaloids; Ergotamine; Male; Pertussis Toxin; Prazosin; Receptors, Adrenergic, alpha; Signal Transduction; Sperm Motility; Spermatozoa; Yohimbine

2009
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury.
    Neuroscience, 2017, 01-06, Volume: 340

    Topics: Animals; Antihypertensive Agents; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Dihydroergotamine; Disease Models, Animal; Drug Evaluation, Preclinical; Dura Mater; Male; Mice, Inbred C57BL; Prazosin; Pyrrolidines; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Serotonin Receptor Agonists; Time Factors; Tryptamines; Vasoconstrictor Agents

2017